Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine but strong initial responses to a third dose

F Mwimanzi, HR Lapointe, PK Cheung… - The Journal of …, 2022 - academic.oup.com
Background Third coronavirus disease 2019 (COVID-19) vaccine doses are broadly
recommended, but immunogenicity data remain limited, particularly in older adults. Methods …
被引用次数：36 相关文章
[PDF] semanticscholar.org

[PDF][PDF] Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose

F Mwimanzi, HR Lapointe… - The Journal of …, 2022 - pdfs.semanticscholar.org
Background. Third coronavirus disease 2019 (COVID-19) vaccine doses are broadly
recommended, but immunogenicity data remain limited, particularly in older adults. Methods …

Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose.

F Mwimanzi, HR Lapointe, PK Cheung… - Journal of Infectious …, 2022 - search.ebscohost.com
Abstract < bold> Background: </bold> Third coronavirus disease 2019 (COVID-19)
vaccine doses are broadly recommended, but immunogenicity data remain limited …
[PDF] oup.com

[PDF][PDF] Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose

F Mwimanzi, HR Lapointe, PK Cheung… - The Journal of …, 2022 - academic.oup.com
Background Third coronavirus disease 2019 (COVID-19) vaccine doses are broadly
recommended, but immunogenicity data remain limited, particularly in older adults. Methods …

Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose

F Mwimanzi, HR Lapointe, PK Cheung… - The Journal of …, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Third coronavirus disease 2019 (COVID-19) vaccine doses are broadly recommended, but …
[PDF] machmb.ca

[PDF][PDF] Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose

F Mwimanzi, HR Lapointe, PK Cheung, Y Sang… - 2022 - machmb.ca
Background. Third coronavirus disease 2019 (COVID-19) vaccine doses are broadly
recommended, but immunogenicity data remain limited, particularly in older adults. Methods …

Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose

F Mwimanzi, HR Lapointe… - The Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Third coronavirus disease 2019 (COVID-19) vaccine doses are broadly
recommended, but immunogenicity data remain limited, particularly in older adults. Methods …
[HTML] europepmc.org

[HTML][HTML] Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine, but strong initial responses to a third dose

F Mwimanzi, HR Lapointe, PK Cheung, Y Sang… - 2022 - europepmc.org
Background Third COVID-19 vaccine doses are broadly recommended, but immunogenicity
data remain limited, particularly in older adults. Methods We measured circulating …

Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine but strong initial responses to a third dose.

F Mwimanzi, HR Lapointe, PK Cheung, Y Sang… - 2022 - cabidigitallibrary.org
Background: Third coronavirus disease 2019 (COVID-19) vaccine doses are broadly
recommended, but immunogenicity data remain limited, particularly in older adults. Methods …
[HTML] nih.gov

[HTML][HTML] Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose

F Mwimanzi, HR Lapointe, PK Cheung… - The Journal of …, 2022 - ncbi.nlm.nih.gov
Background Third coronavirus disease 2019 (COVID-19) vaccine doses are broadly
recommended, but immunogenicity data remain limited, particularly in older adults. Methods …